GE looks to speed drug discovery with new high capacity system

By Melissa Fassbender

- Last updated on GMT

(Image: Getty/YiuCheung)
(Image: Getty/YiuCheung)
GE has introduced a new high capacity system designed to improve productivity in the increasingly complex drug discovery process.

“The drug discovery process is growing in difficulty and length presenting challenges to leaders of drug discovery programs,”​ said Christina Burtsoff-Asp, GE Healthcare Life Sciences global product marketing manager for label-free technologies.

“With escalating cost pressures and increasingly complex disease targets, improving productivity in early drug discovery has been a challenge,” ​she told us.

In response, GE Healthcare Life Sciences has launched the Biacore 8K+, which, with up to 12 microplates, provides eight times higher throughput than a single-needle system, explained Burtsoff-Asp.

According to the company, the new system can automate more than 4,500 drug candidate/disease target binding experiments in a single run. Burtsoff-Asp said the system also can be paired with GE’s Biacore Insight Evaluation Software to evaluate screening and characterization data.

“The use of SPR as a bio-analytical tool has expanded in recent years to cover process optimization and quality control applications as well as early stage drug discovery,”​ said Burtsoff-Asp.

“SPR can support reliable analysis of critical quality attributes and is considered a novel analytical tool for drug product comparability testing.”

Related news

Show more

Related products

show more

SDTM supplemental qualifiers explained

SDTM supplemental qualifiers explained

Content provided by Formedix | 12-May-2023 | White Paper

What are SDTM supplemental qualifiers? In short, these are variables in non-CDISC datasets that cannot be mapped to a variable that matches the SDTM standard....

How clinical trial software can optimize trials

How clinical trial software can optimize trials

Content provided by Formedix | 17-Apr-2023 | White Paper

Companies often have to conduct multiple clinical trials at the same time, which means they've got to be efficient, and compliant with industry regulations....

4 Warning Signs Your Research Site Is in Trouble

4 Warning Signs Your Research Site Is in Trouble

Content provided by Elligo Health Research® | 13-Apr-2023 | Insight Guide

You want your clinical research practice to be a success for your business and your patients, but how can you tell if it’s in trouble? Read this article...

Related suppliers

Follow us

Products

View more

Webinars